A citation-based method for searching scientific literature

Peter Ravn, Chaithanya Madhurantakam, Susan Kunze, Evelyn Matthews, Claire Priest, Siobhan O'Brien, Andie Collinson, Monika Papworth, Maria Fritsch-Fredin, Lutz Jermutus, Lambertus Benthem, Markus Gruetter, Ronald H Jackson. J Biol Chem 2013
Times Cited: 60







List of co-cited articles
666 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inhibition of gastric inhibitory polypeptide signaling prevents obesity.
Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, Yu Ihara, Katsushi Tsukiyama, Heying Zhou, Shimpei Fujimoto, Akira Oku, Kinsuke Tsuda, Shinya Toyokuni,[...]. Nat Med 2002
641
46

Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.
Brian Finan, Tao Ma, Nickki Ottaway, Timo D Müller, Kirk M Habegger, Kristy M Heppner, Henriette Kirchner, Jenna Holland, Jazzminn Hembree, Christine Raver,[...]. Sci Transl Med 2013
331
33

Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions.
Daniela Nasteska, Norio Harada, Kazuyo Suzuki, Shunsuke Yamane, Akihiro Hamasaki, Erina Joo, Kanako Iwasaki, Kimitaka Shibue, Takanari Harada, Nobuya Inagaki. Diabetes 2014
121
26


Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Juan Pablo Frias, Michael A Nauck, Joanna Van, Mark E Kutner, Xuewei Cui, Charles Benson, Shweta Urva, Ruth E Gimeno, Zvonko Milicevic, Deborah Robins,[...]. Lancet 2018
344
26


GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
Paula L McClean, Nigel Irwin, Roslyn S Cassidy, Jens J Holst, Victor A Gault, Peter R Flatt. Am J Physiol Endocrinol Metab 2007
185
25

Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors.
A H Sparre-Ulrich, L S Hansen, B Svendsen, M Christensen, F K Knop, B Hartmann, J J Holst, M M Rosenkilde. Br J Pharmacol 2016
58
25

Pharmacology, physiology, and mechanisms of incretin hormone action.
Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
842
25

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models.
Elizabeth A Killion, Jinghong Wang, Junming Yie, Stone D-H Shi, Darren Bates, Xiaoshan Min, Renee Komorowski, Todd Hager, Liying Deng, Larissa Atangan,[...]. Sci Transl Med 2018
92
25

Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor.
Christoph Parthier, Martin Kleinschmidt, Piotr Neumann, Rainer Rudolph, Susanne Manhart, Dagmar Schlenzig, Jörg Fanghänel, Jens-Ulrich Rahfeld, Hans-Ulrich Demuth, Milton T Stubbs. Proc Natl Acad Sci U S A 2007
186
21

Vaccination against GIP for the treatment of obesity.
Alma Fulurija, Thomas A Lutz, Katja Sladko, Melania Osto, Peter Y Wielinga, Martin F Bachmann, Philippe Saudan. PLoS One 2008
73
21

Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
Piotr A Mroz, Brian Finan, Vasily Gelfanov, Bin Yang, Matthias H Tschöp, Richard D DiMarchi, Diego Perez-Tilve. Mol Metab 2019
85
21


Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.
Mikkel Christensen, Louise Vedtofte, Jens J Holst, Tina Vilsbøll, Filip K Knop. Diabetes 2011
210
20

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.
K Miyawaki, Y Yamada, H Yano, H Niwa, N Ban, Y Ihara, A Kubota, S Fujimoto, M Kajikawa, A Kuroe,[...]. Proc Natl Acad Sci U S A 1999
357
20

Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide.
Victor A Gault, Finbarr P M O'Harte, Patrick Harriott, Peter R Flatt. Biochem Biophys Res Commun 2002
86
20


Molecular basis for negative regulation of the glucagon receptor.
Christopher M Koth, Jeremy M Murray, Susmith Mukund, Azadeh Madjidi, Alexandra Minn, Holly J Clarke, Terence Wong, Vicki Chiang, Elizabeth Luis, Alberto Estevez,[...]. Proc Natl Acad Sci U S A 2012
97
18

GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations.
Carolyn F Deacon, Astrid Plamboeck, Mette M Rosenkilde, Jocelyn de Heer, Jens J Holst. Am J Physiol Endocrinol Metab 2006
46
23

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.
Elizabeth K Speliotes, Cristen J Willer, Sonja I Berndt, Keri L Monda, Gudmar Thorleifsson, Anne U Jackson, Hana Lango Allen, Cecilia M Lindgren, Jian'an Luan, Reedik Mägi,[...]. Nat Genet 2010
18

Therapeutic antibodies directed at G protein-coupled receptors.
Catherine J Hutchings, Markus Koglin, Fiona H Marshall. MAbs 2010
113
16

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
16

Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes.
Nigel Irwin, Paula L McClean, Steven Patterson, Kerry Hunter, Peter R Flatt. Biol Chem 2009
32
31


GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro.
R W Gelling, D H Coy, R A Pederson, M B Wheeler, S Hinke, T Kwan, C H McIntosh. Regul Pept 1997
50
20



N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor.
L S Hansen, A H Sparre-Ulrich, M Christensen, F K Knop, B Hartmann, J J Holst, M M Rosenkilde. Br J Pharmacol 2016
56
17

TCF1 links GIPR signaling to the control of beta cell function and survival.
Jonathan E Campbell, John R Ussher, Erin E Mulvihill, Jelena Kolic, Laurie L Baggio, Xiemen Cao, Yu Liu, Benjamin J Lamont, Tsukasa Morii, Catherine J Streutker,[...]. Nat Med 2016
77
16

Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.
Erina Joo, Norio Harada, Shunsuke Yamane, Toru Fukushima, Daisuke Taura, Kanako Iwasaki, Akiko Sankoda, Kimitaka Shibue, Takanari Harada, Kazuyo Suzuki,[...]. Diabetes 2017
52
19

Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
Nathalie Pamir, Francis C Lynn, Alison M J Buchan, Jan Ehses, Simon A Hinke, J Andrew Pospisilik, Kazumasa Miyawaki, Yuichiro Yamada, Yutaka Seino, Christopher H S McIntosh,[...]. Am J Physiol Endocrinol Metab 2003
97
15


Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans.
Meena Asmar, Lene Simonsen, Sten Madsbad, Bente Stallknecht, Jens Juul Holst, Jens Bülow. Diabetes 2010
97
15

GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis.
Su-Jin Kim, Cuilan Nian, Subashini Karunakaran, Susanne M Clee, Carlos M Isales, Christopher H S McIntosh. PLoS One 2012
101
15

Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.
Tanya Hansotia, Adriano Maida, Grace Flock, Yuichiro Yamada, Katsushi Tsukiyama, Yutaka Seino, Daniel J Drucker. J Clin Invest 2007
211
15

Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain.
Randi Ugleholdt, Jens Pedersen, Maria Rosaria Bassi, Ernst-Martin Füchtbauer, Signe Marie Jørgensen, Hanne-Louise Kissow, Nikolaj Nytofte, Steen Seier Poulsen, Mette Marie Rosenkilde, Yutaka Seino,[...]. J Biol Chem 2011
34
26

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.
Richa Saxena, Marie-France Hivert, Claudia Langenberg, Toshiko Tanaka, James S Pankow, Peter Vollenweider, Valeriya Lyssenko, Nabila Bouatia-Naji, Josée Dupuis, Anne U Jackson,[...]. Nat Genet 2010
475
15

A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.
Brian Finan, Bin Yang, Nickki Ottaway, David L Smiley, Tao Ma, Christoffer Clemmensen, Joe Chabenne, Lianshan Zhang, Kirk M Habegger, Katrin Fischer,[...]. Nat Med 2015
359
15

GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release.
A H Sparre-Ulrich, M N Gabe, L S Gasbjerg, C B Christiansen, B Svendsen, B Hartmann, J J Holst, M M Rosenkilde. Biochem Pharmacol 2017
44
20

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.
Tamer Coskun, Kyle W Sloop, Corina Loghin, Jorge Alsina-Fernandez, Shweta Urva, Krister B Bokvist, Xuewei Cui, Daniel A Briere, Over Cabrera, William C Roell,[...]. Mol Metab 2018
207
15

Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification.
Lisa Getty-Kaushik, Diane H Song, Michael O Boylan, Barbara E Corkey, M Michael Wolfe. Obesity (Silver Spring) 2006
87
13

Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
Yukihiro Fujita, Rhonda D Wideman, Ali Asadi, Gary K Yang, Robert Baker, Travis Webber, Tianjiao Zhang, Rennian Wang, Ziliang Ao, Garth L Warnock,[...]. Gastroenterology 2010
116
13

Gastric inhibitory polypeptide immunoneutralization attenuates development of obesity in mice.
Michael O Boylan, Patricia A Glazebrook, Milos Tatalovic, M Michael Wolfe. Am J Physiol Endocrinol Metab 2015
37
21

A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.
Sameer Mohammad, Rajesh T Patel, Joanne Bruno, Muhammad Siyab Panhwar, Jennifer Wen, Timothy E McGraw. Mol Cell Biol 2014
56
14

Functional GIP receptors are present on adipocytes.
R G Yip, M O Boylan, T J Kieffer, M M Wolfe. Endocrinology 1998
178
13


Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition.
Kentaro Kaneko, Yukiko Fu, Hsiao-Yun Lin, Elizabeth L Cordonier, Qianxing Mo, Yong Gao, Ting Yao, Jacqueline Naylor, Victor Howard, Kenji Saito,[...]. J Clin Invest 2019
44
18

Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment.
Catherine J Hutchings, Gabriella Cseke, Greg Osborne, Jeanette Woolard, Andrei Zhukov, Markus Koglin, Ali Jazayeri, Jahnavi Pandya-Pathak, Christopher J Langmead, Stephen J Hill,[...]. MAbs 2014
25
28

Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.
Urs B Hagemann, Lavinia Gunnarsson, Solène Géraudie, Ulrike Scheffler, Remko A Griep, Herald Reiersen, Alexander R Duncan, Sergej M Kiprijanov. PLoS One 2014
19
36


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.